Parkinson's Disease Clinical Trials in Alabama

13 recruiting studies across 3 cities

All Trials in Alabama

Phase
Trial Phase Location
A Study of Buntanetap in Participants With PDPhase 2/3Birmingham
A Study to Determine if BHV-8000 is Effective, Safe and Tolerable as a Treatment for Adults Living With Early Parkinson's DiseasePhase 2/3Birmingham
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in Participants With Early-Stage Parkinson's DiseasePhase 3Birmingham
Black and African Americans Connections to Parkinson's Disease (BLAAC PD)—Birmingham
Investigating Inhibitory Control Networks in Parkinson's DiseaseN/ABirmingham
Neurophysiological, Behavioral, and Cognitive Networks in Movement DisordersN/ABirmingham
PPMI Clinical - Establishing a Deeply Phenotyped PD Cohort—Birmingham
Parkinson's Foundation PD GENEration Genetic Registry—Birmingham
Stimulus-Evoked Directional Field Potentials to Guide Subthalamic and Pallidal DBS for PDN/ABirmingham
The University of Alabama at Birmingham (UAB) Neuroinflammation in Parkinson's Disease-TSPO- Positron Emission Tomography (PET) SubstudyPhase 1/2Birmingham
Using taVNS to Modulate Cardiovascular Function in Individuals With Neurologic DiseasePhase 1Birmingham
Investigating the Increased Risk of Falls in Individuals With Parkinson's Disease Treated With Deep Brain StimulationN/AHomewood
Low Voltage Electrical Stimulation for Depression in Parkinson's PatientsN/AMobile

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.